Advertisement
Cancer Immunology at the Crossroads

Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved

Edward F. Fritsch, Ute E. Burkhardt, Nir Hacohen and Catherine J. Wu
DOI: 10.1158/2326-6066.CIR-20-0526 Published December 2020

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2020 to February 2021

AbstractFull-text HTMLPDF
Total2099297378

Cited By

Article Information

Volume 8, Issue 12, pp. 1465-1469

DOI 
https://doi.org/10.1158/2326-6066.CIR-20-0526
PubMed 
33262163
Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Published first December 1, 2020.
Copyright & Usage 
©2020 American Association for Cancer Research.

Author Information

  1. Edward F. Fritsch1,2,
  2. Ute E. Burkhardt3,
  3. Nir Hacohen2,4,5, and
  4. Catherine J. Wu1,2,4,6,*
  1. 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  2. 2Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  3. 3Accelerating Cancer Immunotherapy Research, Cambridge, Massachusetts.
  4. 4Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  5. 5Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.
  6. 6Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  1. ↵*Corresponding Author:
    Catherine J. Wu, Dana-Farber Cancer Institute, 450 Brookline Avenue, Dana 520, Boston, MA 02215. Phone: 617-632-5943; Fax: 617-632-6380; E-mail: cwu{at}partners.org
View Full Text
Back to top
View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved
Edward F. Fritsch, Ute E. Burkhardt, Nir Hacohen and Catherine J. Wu
Cancer Immunol Res December 1 2020 (8) (12) 1465-1469; DOI: 10.1158/2326-6066.CIR-20-0526
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement